Related Experiment Video
Updated: Aug 3, 2025

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
Endogenous Endophthalmitis in COVID-19 Patients: A Case Series and Literature Review
Ashish Markan1, Mohit Dogra1, Deeksha Katoch1
1Advanced Eye Center, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Purpose:
To report outcomes in cases of endogenous endophthalmitis (EE) following COVID-19 infection.
Material And Methods:
In a retrospective study, patients with EE, who had a recent history of COVID-19 infection requiring hospital admission were recruited. Necessary demographic details, details of ocular examination, and microbiological details were collected.
Results:
Six patients (10 eyes), with a mean age of 48 + 19.80 years were included. The mean duration of onset of ocular symptoms from the time of diagnosis of COVID was 28.16 + 16.15 days. 8 eyes required surgical intervention, whereas 2 eyes were managed conservatively. Three patients were positive for Candida albicans, two patients were positive for Aspergillus fumigatus, and one patient was a presumed bacterial EE. The majority of the eyes had favorable functional and anatomical outcomes during the post-operative period.
Conclusion:
High-dose corticosteroid therapy in the management of moderate and severe COVID-19 infection may be associated with EE, predominantly fungal.
Related Concept Videos
Endocarditis I: Introduction
Glaucoma: Overview
Endocarditis II: Clinical Features of Infective Endocarditis
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Angle Closure Glaucoma: Treatment
Endocarditis III: Medical Management

